Rchr
J-GLOBAL ID：201401057711592598
Update date: Aug. 25, 2020
Takegawa Naoki
タケガワ ナオキ | Takegawa Naoki
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
Kindai University
About Kindai University
Search "Kindai University"
Detailed information
Research field (1)：
Gastroenterology
Research keywords (5)：
alectinib
, DS-8201a
, cell free DNA
, HER2
, 大腸癌
Papers (9)：
Kimio Yonesaka, Koji Haratani, Shiki Takamura, Hitomi Sakai, Ryoji Kato, Naoki Takegawa, Takayuki Takahama, Kaoru Tanaka, Hidetoshi Hayashi, Masayuki Takeda, et al. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity. Clinical Cancer Research. 2018. 24. 11. 2653-2664
Naoki Takegawa, Kimio Yonesaka. HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti-Epidermal Growth Factor Receptor Therapy. CLINICAL COLORECTAL CANCER. 2017. 16. 4. 247-251
Satomi Watanabe, Takeshi Yoshida, Hisato Kawakami, Naoki Takegawa, Junko Tanizaki, Hidetoshi Hayashi, Masayuki Takeda, Kimio Yonesaka, Junji Tsurutani, Kazuhiko Nakagawa. T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non-Small Cell Lung Cancer. MOLECULAR CANCER THERAPEUTICS. 2017. 16. 11. 2563-2571
Naoki Takegawa, Yoshikane Nonagase, Kimio Yonesaka, Kazuko Sakai, Osamu Maenishi, Yusuke Ogitani, Takao Tamura, Kazuto Nishio, Kazuhiko Nakagawa, Junji Tsurutani. DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance. INTERNATIONAL JOURNAL OF CANCER. 2017. 141. 8. 1682-1689
Naoki Takegawa. Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer. Oncotarget. 2017. 17. 8(46). 80286-80294
ｍore...
Lectures and oral presentations (3)：
The antitumor efficacy of DS-8201a is dependent on the expression levels of HER2 in KRAS mutated colorectal cancer cells
(2018)
アレクチニブ耐性後に小細胞癌転化をしたALK融合遺伝子陽性の肺腺癌の一例
(日本臨床腫瘍学会学術集会抄録 第14回 2016)
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer.
(日本臨床腫瘍学会学術集会抄録 第14回 2016)
Education (1)：
2002 - 2008 University of Fukui
Work history (2)：
2014/04 - 現在 Kindai University Faculty of Medicine
2012/04 - 2014/03 兵庫県立がんセンター 消化器内科 レジデント
Association Membership(s) (5)：
日本緩和医療学会
, 日本臨床腫瘍学会
, JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY
, JAPANESE SOCIETY OF GASTROENTEROLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
